Compugen (CGEN) Other Non-Current Assets (2009 - 2026)
Compugen (CGEN) reported Other Non-Current Assets of $1.3 million for Q1 2026, down 20.84% on a YoY basis from $1.6 million in Q1 2025, and little changed sequentially from $1.3 million in Q4 2025.
Compugen (CGEN) Other Non-Current Assets (2009 - 2026) Analysis & Trends
Compugen (CGEN) has 18 years of Other Non-Current Assets data on file, last reported at $1.3 million in Q1 2026.
- For the quarter ending Q1 2026, Other Non-Current Assets fell 20.84% year-over-year to $1.3 million; the trailing twelve-month figure through Mar 2026 stood at $1.3 million (down 20.84% YoY), and the FY2025 full-year result was $1.3 million, down 31.51% from the prior year.
- Other Non-Current Assets was little changed at $1.3 million in Q1 2026, from $1.3 million in the prior quarter.
- In the past five years, Other Non-Current Assets ranged from a high of $1.9 million in Q1 2022 to a low of $922000.0 in Q2 2024.
- A 5-year average of $1.6 million and a median of $1.7 million in 2025 frame the typical range for Other Non-Current Assets.
- Across the five-year window, Other Non-Current Assets sank 51.78% in 2024 and surged 88.5% in 2025, its largest moves.
- Tracing CGEN's Other Non-Current Assets over 5 years: stood at $1.9 million in 2022, then tumbled by 35.07% to $1.2 million in 2023, then jumped by 53.12% to $1.9 million in 2024, then tumbled by 31.51% to $1.3 million in 2025, then increased by 0.15% to $1.3 million in 2026.
- Business Quant data shows CGEN's Other Non-Current Assets at $1.3 million in Q1 2026, $1.3 million in Q4 2025, and $1.7 million in Q3 2025.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Other Non-Current Assets (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 68,785.72 Bn | 68,785.72 Bn | - | 1.02 Mn |
| 2 | Nanobiotix | 1,895.57 Bn | 1,895.51 Bn | - | - |
| 3 | BeOne Medicines | 471.35 Bn | 466.56 Bn | 1.35 Bn | 104.24 Mn |
| 4 | NuCana | 279.75 Bn | 279.75 Bn | - | - |
| 5 | Vertex Pharmaceuticals | 120.24 Bn | 113.00 Bn | 2.59 Bn | 1.26 Bn |
| 6 | Regeneron Pharmaceuticals | 67.80 Bn | 59.04 Bn | 3.31 Bn | 2.13 Bn |
| 7 | Belite Bio | 62.51 Bn | 62.51 Bn | - | 289.41 Mn |
| 8 | Argenx Se | 57.38 Bn | 57.38 Bn | 1.41 Bn | 124.00 Mn |
| 9 | Revolution Medicines | 37.78 Bn | 37.78 Bn | - | 14.48 Mn |
| 10 | Compugen | 221.26 Mn | 129.51 Mn | 352,000.00 | 1.30 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 1.30 Mn |
| Dec 31, 2025 | 1.29 Mn |
| Sep 30, 2025 | 1.73 Mn |
| Jun 30, 2025 | 1.74 Mn |
| Mar 31, 2025 | 1.64 Mn |
| Dec 31, 2024 | 1.89 Mn |
| Sep 30, 2024 | 1.10 Mn |
| Jun 30, 2024 | 922,000.00 |
| Mar 31, 2024 | 934,000.00 |
| Dec 31, 2023 | 1.23 Mn |
| Sep 30, 2023 | 1.91 Mn |
| Jun 30, 2023 | 1.91 Mn |
| Mar 31, 2023 | 1.91 Mn |
| Dec 31, 2022 | 1.90 Mn |
| Sep 30, 2022 | 1.91 Mn |
| Jun 30, 2022 | 1.91 Mn |
| Mar 31, 2022 | 1.92 Mn |
| Dec 31, 2021 | 3.13 Mn |
| Sep 30, 2021 | 1.91 Mn |
| Jun 30, 2021 | 1.91 Mn |